NFKB1 and cancer: Of note, inactivating mutations of IκBα occurred predominantly in EBV-negative cHL cases, indicating that NF-κB is aberrantly activated through different mechanisms in cancer, and that EBV infection can substitute for some genetic lesions in cHL cells.